Key Insights

Highlights

Success Rate

88% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

8.3%

1 terminated out of 12 trials

Success Rate

87.5%

+1.0% vs benchmark

Late-Stage Pipeline

8%

1 trials in Phase 3/4

Results Transparency

14%

1 of 7 completed with results

Key Signals

1 with results88% success

Data Visualizations

Phase Distribution

12Total
Not Applicable (11)
P 3 (1)

Trial Status

Completed7
Unknown2
Recruiting1
Not Yet Recruiting1
Terminated1

Trial Success Rate

87.5%

Benchmark: 86.5%

Based on 7 completed trials

Clinical Trials (12)

Showing 12 of 12 trials
Showing all 12 trials

Research Network

Activity Timeline